Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”

Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2024;30(4):997-999. Published online July 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0588

View: 1163 Download: 40

Editorial

Elimination of viral hepatitis: How far are we?: Editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”

Eun Ju Cho

Clin Mol Hepatol. 2024;30(4):663-664. Published online July 22, 2024

DOI: https://doi.org/10.3350/cmh.2024.0557

View: 1151 Download: 43 Web of Science: 1 Crossref: 1

Review

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0186

View: 9963 Download: 416 Web of Science: 15 Crossref: 17

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 14124 Download: 319 Web of Science: 87 Crossref: 87

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 9809 Download: 248 Web of Science: 21 Crossref: 22

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 9416 Download: 81 Web of Science: 3 Crossref: 3

Original Article

Socioeconomic costs of liver disease in Korea

Sunmi Lee, Woojin Chung, Kyung-Rae Hyun

Clin Mol Hepatol. 2011;17(4):274-291. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.274

View: 16943 Download: 54 Crossref: 21

3

Factors associated with Liver stiffness in chronic Liver disease

Da Mi Lee, M.D., Eun Joon Moon, M.D., Joo An Hwang, M.D., Min Suk Lee, M.D., Jae Youn Cheong, M.D., Sung Won Cho, M.D., Yeong Bae Kim, M.D. Dong Joon Kim, M.D. Seong Gyu Hwang, M.D. Jin Mo Yang, M.D.

Clin Mol Hepatol. 2009;15(4):464-473. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.464

View: 5133 Download: 32 Crossref: 4

Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant

Jeong Ki Kim, M.D. Seong Gyu Hwang, M.D. Hyeuk Park, M.D. Hong Youp Choi, M.D. Hyo Jin Cho, B.S. Kwang Hyun Ko, M.D. Sung Pyo Hong, M.D. Pil Won Park, M.D. Nam Keun Kim, Ph.D. and Kyu Sung Rim, M.D.

Clin Mol Hepatol. 2005;11(3):227-242. Published online January 1, 1970

View: 3291 Download: 14

Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection

Park Neunghwa , Sin Jeongu , Park Jongho , Bang Seongjo , Kim Daehyeon , Ju Gwanglo , Kim Doha

Clin Mol Hepatol. 2003;9(4):293-303. Published online January 1, 1970

View: 2625 Download: 12

Efficacy of Lamivudine Re-treatment and Relapse Patterns after Initial Lamivudine Treatment for Chronic Hepatitis B Infection

Jong Ho Park, M.D., Neung Hwa Park, M.D., Jung Woo Shin, M.D., Sung-Jo Bang, M.D., Dae-Hyun Kim, M.D., Kwang Ro Joo, M.D. and Do Ha Kim, M.D.

Clin Mol Hepatol. 2003;9(3):188-197. Published online January 1, 1970

View: 2748 Download: 13

2

Special Oromucosal Cytokine Therapy : Mechanism(s) of Action

Michael G. Tovey

Clin Mol Hepatol. 2002;8(2):125-131. Published online January 1, 1970

View: 4398 Download: 28

3

The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection

Neung Hwa Park,Kwang Ro Joo,Do Ha Kim

Clin Mol Hepatol. 2001;7(1):77-89. Published online January 1, 2000

View: 2710 Download: 20

The Role of Dendritic Cell , HLA-DR and CD8+ Presenting Lymphocytes in Chronic Viral Hepatitis : An Immunohistochemical Study

Sang Wook Choi,Don Hyun Jo,Sung Soo Kim,Jin Mo Yang,Byung Min An,Nam Ik Han,Chang Don Lee,Gyu Won Jung,Hee Sik Sun

Clin Mol Hepatol. 2000;6(4):448-455. Published online January 1, 2000

View: 2137 Download: 13

Clinical Study of the Acute Hepatitis due to Salmonella typhi

Sang Woo Lee,Seung Won Seo,Heyng Woong Yang,Jae Kyu Seong,Seung Min Lee,Byung Seok Lee,Nam Jae Kim,Heon Young Lee

Clin Mol Hepatol. 2000;6(3):350-359. Published online January 1, 2000

View: 2641 Download: 36

Novel Maintenance Therapy with Lamivudine in Patients with Chronic Active Viral Hepatitis B

Sung Pyo Hong, M.D., Chang Il Kwon, M.D., June Sung Lee, M.D., Kyung Chul Kim, M.D., Sung Kyu Hwang, M.D., Pil Won Park, M.D., Gyu Sung Rim, M.D. and Sehyun Kim, Ph.D.

Clin Mol Hepatol. 2000;6(3):301-310. Published online January 1, 2000

View: 2426 Download: 12

Evaluation of Oral Thymomodulin Effect on the Patients with Chronic Viral Hepatitis B

Chul Hun Chung , Soong Hwan Lee , Yong Hyeon Jo , Yeon Soo kim , Seung Woo Nam , Oh Young Lee , Dong Soo Ha , Joo Hyun Sohn , Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):47-53.

View: 3478 Download: 40

1 |

Viewed By 7185	MAFLD: How is it different from NAFLD?
Viewed By 6634	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5468	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5257	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4734	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 269	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 181	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search